FDA panel gives nod to Novavax COVID-19 shot ...Middle East

An outside advisory panel voted overwhelmingly to recommend the Food and Drug Administration (FDA) authorize a COVID-19 vaccine made by Novavax for use in adults, a move that could lead to adding a fourth vaccine to the U.S. arsenal. The FDA's vaccine advisory panel voted 21-0, with one abstention. The FDA does not have to follow the panel's recommendation, though it often does. Novavax's two-dose vaccine was about 90 percent effective at preventing mild, moderate and severe COVID-19 during clinical trials. But critically, the trials were conducted before the omicron variant and panel members expressed concern about whether the efficacy would hold up against the current variants.

Hence then, the article about fda panel gives nod to novavax covid 19 shot was published today ( Tuesday 07/06/2022 - 10:53 PM ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA panel gives nod to Novavax COVID-19 shot )

Also on site :

• Quote of the Day: French Novelist Marcel Proust on Gratitude and the People Who Make Our Souls Blossom
• Inflatable Tanning Pool Loungers Are Going Viral, and Amazon’s ‘Super Comfy’ $28 Version Is a Shopper Favorite
• Walmart’s ‘Super Cute’ $3 Retro Bag Charm Keychain Is an Affordable Way to Try the Viral Accessory Trend